# Bisichem

**Canonical:** https://apis.io/providers/bisichem/  
**Website:** https://bisichem.com  
**APIs profiled:** 0

BiSiChem is a leading biotech company focused on discovery and development of innovative therapeutic drugs in immuno‑oncology, targeted therapy, and neuro‑degenerative diseases. They partner early‑stage programs, retain profit rights, and aim for first‑in‑class or second‑generation small‑molecule drugs, emphasizing good lives, better innovation, and best therapy.

## Kin Score — 7.1 / 100 (minimal)

Scored 2026-10-23 under rubric 0.25.0. Trend: flat (+0.0 from 7.1).

| Facet | Score |
|---|---|
| Discoverability | 46.4 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 19.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 5.9 (matched via fallback).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## Security (1)

- **Bisichem Domain Security** — TLSv1.2

## Tags

Biotechnology, Drug Discovery, Immuno-Oncology, Targeted Therapy, Neurodegenerative

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/bisichem/). Scores are computed from the provider's own public artifacts under a published rubric.